Jake Auchincloss discussing how PBM regulations can unlock domestic manufacturing for Rx drugs

Unlocking domestic manufacturing of generics & biosimilars takes cost out of health care, lowers Rx drug prices for patients, and creates good jobs. The policy to get us there can be bipartisan.